Italia markets close in 6 hours 33 minutes

ILMN Jan 2025 220.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,15000,0000 (0,00%)
In data: 09:38AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,1500
Aperto2,1500
Denaro0,0000
Lettera0,0000
Prezzo d'esercizio220,00
Scadenza2025-01-17
Min-Max giorno2,1500 - 2,1500
Contratto - Min-MaxN/D
Volume126
Open InterestN/D
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera